What MemoHive Would Need to Change to Earn a Recommendation
Six specific, achievable changes — and the hardest one is already done.
2 September 2026Read →
Every MemoHive review on this site — the fully disclosed label, the 540 mg BCAA share, and each amount against its studied range.
Six specific, achievable changes — and the hardest one is already done.
Reward the transparency, mark down the doses, and land above average rather than good.
Consistent, responsible selling pages that stop short of analysing their own numbers.
A two-capsule daily supplement — and the gummy or drink mislabels signal recycled content.
Nine checks, fifteen minutes, and almost every common complaint never happens to you.
Four real interactions in one bottle — and, unusually, a label that lets you check them.
Useful transparency for a group that needs it, sold to a group that should see a doctor first.
Judge any review by whether it goes past the label and into the research.
An unusually long verified column for this category, and three honest gaps.
Fifteen minutes of setup, and a memory trial that can actually tell you something.
Convenience is the product; studied doses and real standardisations are what you trade away.
The same ingredients at studied doses would be a genuinely different product.
Possible but unproven, resting entirely on an under-dosed and unstandardised bacopa.
Fair value for transparency, poor value for cognitive milligrams.
Three bottles — the only pack that matches both the guarantee and the ingredient.
Month one builds a habit and rules out side effects. It cannot judge the memory claim.
A mild profile with four interaction cautions worth a pharmacy conversation.
A real, documented interaction in a product aimed at the people most likely to be on warfarin.
A 60-day window on a product whose lead ingredient needs 84 days.
Inconsistent anchors that cancel each other out — judge the real totals instead.
A sports claim leaking into a brain formula, and under-dosed for sports too.
Transparency is necessary, not sufficient — and this product shows the difference.
The weakest inclusion by dose, and the one with the warfarin problem.
Below the studied dose, and standardised differently from the trial extract.
The formula's one properly dosed ingredient, studied mostly in a combination this product does not use.
A genuinely evidenced memory ingredient, under-dosed and unstandardised.
Five legitimate ingredients, four checkable shortfalls, one that reaches its range.
Legitimate and unusually well-behaved. The criticism is dose, not honesty.
Genuine interactions, modest benefit, and one real displacement concern.
A real total, made of something different from what the comparison implies.
Over half the formula is an ingredient with no cognitive evidence, at a tenth of its own studied dose.
Rewarding the transparency, then reading what the transparency actually reveals.
Honest labelling, conventional ingredients, and amounts that mostly do not reach the evidence.
The most transparent label in its category, attached to amounts that mostly miss the research.
Honest and checkable, but you are buying transparency rather than studied doses.